Adaptive Diarylalkane-Based Solutions for Niche Environments

Publication ID: 24-11857657_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Diarylalkane-Based Solutions for Niche Environments,” Published Technical Disclosure No. 24-11857657_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857657_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,657.

Summary of the Inventive Concept

This inventive concept adapts diarylalkane-based compositions to address specific skin health challenges in unique operational environments, including high-altitude, extreme weather, disaster relief, high-security, and extreme cold scenarios.

Background and Problem Solved

The original patent disclosed diarylalkane-based compositions for treating skin pigmentation and conditions. However, these compositions may not be effective in niche environments with distinct skin health challenges. This inventive concept addresses these limitations by developing specialized diarylalkane-based solutions tailored to the specific needs of these environments.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of diarylalkane-based compositions and systems, each adapted to counteract the effects of specific environmental stressors on skin health. For example, in high-altitude environments, the composition may be formulated to counteract the effects of low oxygen levels on skin health. In extreme weather conditions, the composition may be designed to protect against temperature and humidity extremes. In disaster relief scenarios, the composition may be selected for its ability to promote skin healing in resource-constrained environments. In high-security applications, the composition may be adapted for use in secure facilities or sensitive environments. In extreme cold environments, the composition may be formulated to protect against cold-induced skin damage.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptation of diarylalkane-based compositions to address specific skin health challenges in niche environments, which is not addressed by the original patent. The inventive step is the development of specialized formulations and systems that take into account the unique environmental stressors and skin health needs of these environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include different diarylalkane compounds, formulations, or delivery systems tailored to specific environments or skin health needs. For example, a variant of the composition may be developed for use in space exploration or for treating skin conditions in athletes.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including pharmaceuticals, cosmetics, and disaster relief. The target market includes consumers and organizations operating in niche environments, such as high-altitude resorts, extreme weather zones, disaster relief organizations, high-security facilities, and extreme cold environments.

CPC Classifications

SectionClassGroup
A A61 A61K8/347
A A61 A61K8/31
A A61 A61K8/4973
A A61 A61K8/9789
A A61 A61K8/9794
A A61 A61K31/015
A A61 A61K31/05
A A61 A61K31/085
A A61 A61K31/09
A A61 A61K31/357
A A61 A61K31/40
A A61 A61K31/704
A A61 A61Q19/02
C C07 C07C39/15
C C07 C07C39/367
C C07 C07C41/26
C C07 C07C41/32
C C07 C07C43/23
C C07 C07C45/673
C C07 C07C49/835
C C07 C07C215/74
C C07 C07D321/12
A A61 A61K2800/782
Y Y02 Y02A50/30

Field of Art

Dermatological and pharmaceutical compositions, specifically focused on enzyme inhibition, skin treatment, and environmental adaptations for topical formulations

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with expertise in pharmaceutical chemistry, dermatological formulation, and enzyme inhibition techniques, holding advanced degrees in chemistry or pharmacology with practical experience in developing topical skin treatments

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's diarylalkane compositions provide a foundational framework for environmental adaptations. The PTD's variations represent predictable extensions of known skin treatment technologies by applying established diarylalkane compounds to specific environmental contexts. The technical modifications represent routine optimization within the existing scientific understanding of enzyme inhibition and skin health interventions.

Obvious Combinations & Variations

Source Patent Element
Diarylalkane compounds for treating skin pigmentation and reducing signs of aging
PTD Variation
Adapting diarylalkane compositions for high-altitude, extreme weather, and disaster relief environments
Obviousness Reasoning
A PHOSITA would recognize that skin health challenges vary by environment, and modifying existing compositions to address specific stressors represents a predictable design choice using known formulation techniques
Source Patent Element
Melanin inhibition and skin tone correction methods
PTD Variation
Developing specialized diarylalkane formulations for specific environmental conditions like extreme cold or high-security scenarios
Obviousness Reasoning
Tailoring existing pharmaceutical compositions to unique operational contexts is a standard practice in pharmaceutical development, representing an obvious variation to a skilled practitioner
Source Patent Element
Neutralization of active oxygen species for skin treatment
PTD Variation
Creating compositions that specifically counteract environmental stressors like low oxygen levels or temperature extremes
Obviousness Reasoning
Extending antioxidant and protective mechanisms to address environmental challenges is a logical and predictable application of existing skin treatment technologies
Source Patent Element
Diarylalkane compounds with enzyme inhibition properties
PTD Variation
Developing systems for inhibiting binuclear enzymes in specialized environments like high-security facilities
Obviousness Reasoning
Applying known enzyme inhibition techniques to specific operational contexts represents a routine optimization within the existing scientific understanding of pharmaceutical interventions
Source Patent Element
Topical compositions for skin health and pigmentation control
PTD Variation
Formulating diarylalkane-based solutions for resource-constrained environments like disaster relief scenarios
Obviousness Reasoning
Adapting existing pharmaceutical technologies to address specific contextual challenges is a standard approach in medical and pharmaceutical product development
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857657 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations obvious, as the proposed adaptations represent predictable extensions of known diarylalkane compositions through routine optimization and design choices within the established pharmaceutical and dermatological arts.

Original Patent Information

Patent NumberUS 11,857,657
TitleDiarylalkanes as potent inhibitors of binuclear enzymes
Assignee(s)Unigen, Inc.